Dissecting the tumour immune microenvironment in merkel cell carcinoma based on a machine learning framework

References

• Becker JC, Stang A, DeCaprio JA, et al. Merkel cell carcinoma. Nat Rev Dis Primers. 2017;3:17077. doi: 10.1038/nrdp.2017.77.
   PubMed Web of Science ®Google Scholar
• DeCaprio JA. Molecular pathogenesis of merkel cell carcinoma. Annu Rev Pathol. 2021;16:69–91. doi: 10.1146/annurev-pathmechdis-012419-032817.
   PubMed Web of Science ®Google Scholar
• Feng H, Shuda M, Chang Y, et al. Clonal integration of a polyomavirus in human merkel cell carcinoma. Science. 2008;319(5866):1096–1100. doi: 10.1126/science.1152586.
   PubMed Web of Science ®Google Scholar
• Sihto H, Kukko H, Koljonen V, et al. Clinical factors associated with merkel cell polyomavirus infection in merkel cell carcinoma. J Natl Cancer Inst. 2009;101(13):938–945. doi: 10.1093/jnci/djp139.
   PubMedGoogle Scholar
• Bilotta MT, Antignani A, Fitzgerald DJ. Managing the TME to improve the efficacy of cancer therapy. Front Immunol. 2022;13:954992. doi: 10.3389/fimmu.2022.954992.
   PubMed Web of Science ®Google Scholar
• Cerro PA, Mascaraque M, Gallego-Rentero M, et al. Tumor microenvironment in non-melanoma skin cancer resistance to photodynamic therapy. Front Oncol. 2022;12:970279. doi: 10.3389/fonc.2022.970279.
   PubMed Web of Science ®Google Scholar
• Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19(11):1423–1437. doi: 10.1038/nm.3394.
   PubMed Web of Science ®Google Scholar
• Lipson EJ, Vincent JG, Loyo M, et al. PD-L1 expression in the merkel cell carcinoma microenvironment: association with inflammation, merkel cell polyomavirus and overall survival. Cancer Immunol Res. 2013;1(1):54–63. doi: 10.1158/2326-6066.CIR-13-0034.
   PubMed Web of Science ®Google Scholar
• Walsh NM, Fleming KE, Hanly JG, et al. A morphological and immunophenotypic map of the immune response in merkel cell carcinoma. Hum Pathol. 2016;52:190–196. doi: 10.1016/j.humpath.2016.02.002.
   PubMed Web of Science ®Google Scholar
• Feldmeyer L, Hudgens CW, Ray-Lyons G, et al. Density, distribution, and composition of immune infiltrates correlate with survival in merkel cell carcinoma. Clin Cancer Res. 2016;22(22):5553–5563. doi: 10.1158/1078-0432.CCR-16-0392.
   PubMed Web of Science ®Google Scholar
• Kretz-Rommel A, Qin F, Dakappagari N, et al. CD200 expression on tumor cells suppresses antitumor immunity: new approaches to cancer immunotherapy. J Immunol. 2007;178(9):5595–5605. doi: 10.4049/jimmunol.178.9.5595.
   PubMed Web of Science ®Google Scholar
• Moreaux J, Hose D, Reme T, et al. CD200 is a new prognostic factor in multiple myeloma. Blood. 2006;108(13):4194–4197. doi: 10.1182/blood-2006-06-029355.
   PubMed Web of Science ®Google Scholar
• Tonks A, Hills R, White P, et al. CD200 as a prognostic factor in acute myeloid leukaemia. Leukemia. 2007;21(3):566–568. doi: 10.1038/sj.leu.2404559.
   PubMed Web of Science ®Google Scholar
• Gaiser MR, Weis C-A, Gaiser T, et al. Merkel cell carcinoma expresses the immunoregulatory ligand CD200 and induces immunosuppressive macrophages and regulatory T cells. Oncoimmunology. 2018;7(5):e1426517. doi: 10.1080/2162402X.2018.1426517.
   PubMed Web of Science ®Google Scholar
• Daily K, Coxon A, Williams JS, et al. Assessment of cancer cell line representativeness using microarrays for merkel cell carcinoma. J Invest Dermatol. 2015;135(4):1138–1146. doi: 10.1038/jid.2014.518.
   PubMed Web of Science ®Google Scholar
• Harms PW, Patel RM, Verhaegen ME, et al. Distinct gene expression profiles of viral- and nonviral-associated merkel cell carcinoma revealed by transcriptome analysis. J Invest Dermatol. 2013;133(4):936–945. doi: 10.1038/jid.2012.445.
   PubMed Web of Science ®Google Scholar
• Waltari M, Sihto H, Kukko H, et al. Association of merkel cell polyomavirus infection with tumor p53, KIT, stem cell factor, PDGFR-alpha and survival in merkel cell carcinoma. Int J Cancer. 2011;129(3):619–628. doi: 10.1002/ijc.25720.
   PubMed Web of Science ®Google Scholar
• Bhatia K, Goedert JJ, Modali R, et al. Merkel cell carcinoma subgroups by merkel cell polyomavirus DNA relative abundance and oncogene expression. Int J Cancer. 2010;126(9):2240–2246. doi: 10.1002/ijc.24676.
   PubMed Web of Science ®Google Scholar
• Li Y, Jiang T, Zhou W, et al. Pan-cancer characterization of immune-related lncRNAs identifies potential oncogenic biomarkers. Nat Commun. 2020;11(1):1000. doi: 10.1038/s41467-020-14802-2.
   PubMed Web of Science ®Google Scholar
• Jiang T, Zhou W, Chang Z, et al. ImmReg: the regulon atlas of immune-related pathways across cancer types. Nucleic Acids Res. 2021;49(21):12106–12118. doi: 10.1093/nar/gkab1041.
   PubMed Web of Science ®Google Scholar
• Thorsson V, Gibbs DL, Brown SD, et al. The immune landscape of cancer. Immunity. 2018;48(4):812–830 e14. doi: 10.1016/j.immuni.2018.03.023.
   PubMed Web of Science ®Google Scholar
• Luca BA, Steen CB, Matusiak M, et al. Atlas of clinically distinct cell states and ecosystems across human solid tumors. Cell. 2021;184(21):5482–5496 e28. doi: 10.1016/j.cell.2021.09.014.
   PubMed Web of Science ®Google Scholar
• Suva ML, Tirosh I. Single-Cell RNA sequencing in cancer: lessons learned and emerging challenges. Mol Cell. 2019;75(1):7–12. doi: 10.1016/j.molcel.2019.05.003.
   PubMed Web of Science ®Google Scholar
• Rolong A, Chen B, Lau KS. Deciphering the cancer microenvironment from bulk data with EcoTyper. Cell. 2021;184(21):5306–5308. doi: 10.1016/j.cell.2021.09.028.
   PubMed Web of Science ®Google Scholar
• McNally DR, Elemento O, Melnick A. Dissecting bulk transcriptomes of diffuse large B cell lymphoma. Cancer Cell. 2021;39(10):1305–1307. doi: 10.1016/j.ccell.2021.09.006.
   PubMed Web of Science ®Google Scholar
• Newman AM, Steen CB, Liu CL, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019;37(7):773–782. doi: 10.1038/s41587-019-0114-2.
   PubMed Web of Science ®Google Scholar
• Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504. doi: 10.1101/gr.1239303.
   PubMed Web of Science ®Google Scholar
• Yu G, Wang L-G, Han Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–287. doi: 10.1089/omi.2011.0118.
   PubMed Web of Science ®Google Scholar
• Gu Z, Hubschmann D. Simplify enrichment: a bioconductor package for clustering and visualizing functional enrichment results. Genom Proteom Bioinform. 2023;21(1):190–202. doi: 10.1016/j.gpb.2022.04.008.
   PubMed Web of Science ®Google Scholar
• Liberzon A, Birger C, Thorvaldsdóttir H, et al. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1(6):417–425. doi: 10.1016/j.cels.2015.12.004.
   PubMed Web of Science ®Google Scholar
• Bhattacharya S, Dunn P, Thomas CG, et al. ImmPort, toward repurposing of open access immunological assay data for translational and clinical research. Sci Data. 2018;5:180015. doi: 10.1038/sdata.2018.15.
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–15550. doi: 10.1073/pnas.0506580102.
   PubMed Web of Science ®Google Scholar
• Chteinberg E, Vogt J, Kolarova J, et al. The curious case of merkel cell carcinoma: epigenetic youth and lack of pluripotency. Epigenetics. 2020;15(12):1319–1324. doi: 10.1080/15592294.2020.1773096.
   PubMed Web of Science ®Google Scholar
• Kervarrec T, Samimi M, Guyétant S, et al. Histogenesis of merkel cell carcinoma: a comprehensive review. Front Oncol. 2019;9:451. doi: 10.3389/fonc.2019.00451.
   PubMed Web of Science ®Google Scholar
• Tilling T, Moll I. Which are the cells of origin in merkel cell carcinoma? J Skin Cancer. 2012;2012:680410. doi: 10.1155/2012/680410.
   PubMedGoogle Scholar
• Ostrowski SM, Wright MC, Bolock AM, et al. Ectopic Atoh1 expression drives merkel cell production in embryonic, postnatal and adult mouse epidermis. Development. 2015;142(14):2533–2544. doi: 10.1242/dev.123141.
   PubMed Web of Science ®Google Scholar
• Samimi M. Immune checkpoint inhibitors and beyond: an overview of immune-based therapies in merkel cell carcinoma. Am J Clin Dermatol. 2019;20(3):391–407. doi: 10.1007/s40257-019-00427-9.
   PubMed Web of Science ®Google Scholar
• Sur M, AlArdati H, Ross C, et al. TdT expression in merkel cell carcinoma: potential diagnostic pitfall with blastic hematological malignancies and expanded immunohistochemical analysis. Mod Pathol. 2007;20(11):1113–1120. doi: 10.1038/modpathol.3800936.
   PubMed Web of Science ®Google Scholar
• Zur Hausen A, Rennspiess D, Winnepenninckx V, et al. Early B-cell differentiation in merkel cell carcinomas: clues to cellular ancestry. Cancer Res. 2013;73(16):4982–4987. doi: 10.1158/0008-5472.CAN-13-0616.
   PubMed Web of Science ®Google Scholar
• Theisen DJ, Davidson JT, Briseño CG, et al. WDFY4 is required for cross-presentation in response to viral and tumor antigens. Science. 2018;362(6415):694–699. doi: 10.1126/science.aat5030.
   PubMed Web of Science ®Google Scholar
• Conway KL, Kuballa P, Khor B, et al. ATG5 regulates plasma cell differentiation. Autophagy. 2013;9(4):528–537. doi: 10.4161/auto.23484.
   PubMed Web of Science ®Google Scholar
• Kochenderfer JN, Rosenberg SA. Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors. Nat Rev Clin Oncol. 2013;10(5):267–276. doi: 10.1038/nrclinonc.2013.46.
   PubMed Web of Science ®Google Scholar
• Schuh E, Berer K, Mulazzani M, et al. Features of human CD3 + CD20+ T cells. J Immunol. 2016;197(4):1111–1117. doi: 10.4049/jimmunol.1600089.
   PubMed Web of Science ®Google Scholar
• Ellett F, Pase L, Hayman JW, et al. mpeg1 promoter transgenes direct macrophage-lineage expression in zebrafish. Blood. 2011;117(4):e49-56–e56. doi: 10.1182/blood-2010-10-314120.
   PubMed Web of Science ®Google Scholar
• Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16(9):582–598. doi: 10.1038/nrc.2016.73.
   PubMed Web of Science ®Google Scholar
• Fan K, Spassova I, Gravemeyer J, et al. Merkel cell carcinoma-derived exosome-shuttle miR-375 induces fibroblast polarization by inhibition of RBPJ and p53. Oncogene. 2021;40(5):980–996. doi: 10.1038/s41388-020-01576-6.
   PubMed Web of Science ®Google Scholar
• Noy R, Pollard JW. Tumor-associated macrophages: from mechanisms to therapy. Immunity. 2014;41(1):49–61. doi: 10.1016/j.immuni.2014.06.010.
   PubMed Web of Science ®Google Scholar
• DeNardo DG, Ruffell B. Macrophages as regulators of tumour immunity and immunotherapy. Nat Rev Immunol. 2019;19(6):369–382. doi: 10.1038/s41577-019-0127-6.
   PubMed Web of Science ®Google Scholar
• Qiu H, et al. SLIT2 is epigenetically silenced in ovarian cancers and suppresses growth when activated. Asian Pac J Cancer Prev. 2011;12(3):791–795.
   PubMedGoogle Scholar
• Kaul K, Benej M, Mishra S, et al. Slit2-mediated metabolic reprogramming in bone marrow-derived macrophages enhances antitumor immunity. Front Immunol. 2021;12:753477. doi: 10.3389/fimmu.2021.753477.
   PubMed Web of Science ®Google Scholar
• Morigny P, Kaltenecker D, Zuber J, et al. Association of circulating PLA2G7 levels with cancer cachexia and assessment of darapladib as a therapy. J Cachexia Sarcopenia Muscle. 2021;12(5):1333–1351. doi: 10.1002/jcsm.12758.
   PubMed Web of Science ®Google Scholar
• Vegliante MC, Mazzara S, Zaccaria GM, et al. NR1H3 (LXRalpha) is associated with pro-inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b-cell lymphoma. Hematol Oncol. 2022;40(5):864–875. doi: 10.1002/hon.3050.
   PubMed Web of Science ®Google Scholar
• Yuan K, Feng Y, Wang H, et al. FGL2 is positively correlated with enhanced antitumor responses mediated by T cells in lung adenocarcinoma. PeerJ. 2020;8:e8654. doi: 10.7717/peerj.8654.
   PubMed Web of Science ®Google Scholar
• Nowell CS, Radtke F. Notch as a tumour suppressor. Nat Rev Cancer. 2017;17(3):145–159. doi: 10.1038/nrc.2016.145.
   PubMed Web of Science ®Google Scholar
• Gravemeyer J, Lange A, Ritter C, et al. Classical and variant merkel cell carcinoma cell lines display different degrees of neuroendocrine differentiation and epithelial-mesenchymal transition. J Invest Dermatol. 2021;141(7):1675–1686 e4. doi: 10.1016/j.jid.2021.01.012.
   PubMed Web of Science ®Google Scholar
• Ertosun MG, Hapil FZ, Osman Nidai O. E2F1 transcription factor and its impact on growth factor and cytokine signaling. Cytokine Growth Factor Rev. 2016;31:17–25. doi: 10.1016/j.cytogfr.2016.02.001.
   PubMed Web of Science ®Google Scholar
• Kent LN, Bae S, Tsai S-Y, et al. Dosage-dependent copy number gains in E2f1 and E2f3 drive hepatocellular carcinoma. J Clin Invest. 2017;127(3):830–842. doi: 10.1172/JCI87583.
   PubMed Web of Science ®Google Scholar
• Harms PW, Harms KL, Moore PS, et al. The biology and treatment of merkel cell carcinoma: current understanding and research priorities. Nat Rev Clin Oncol. 2018;15(12):763–776. doi: 10.1038/s41571-018-0103-2.
   PubMed Web of Science ®Google Scholar
• Yuan X, Wang J, Huang Y, et al. Single-cell profiling to explore immunological heterogeneity of tumor microenvironment in breast cancer. Front Immunol. 2021;12:643692. doi: 10.3389/fimmu.2021.643692.
   PubMed Web of Science ®Google Scholar
• Ma J, Huang L, Hu D, et al. The role of the tumor microbe microenvironment in the tumor immune microenvironment: bystander, activator, or inhibitor? J Exp Clin Cancer Res. 2021;40(1):327. doi: 10.1186/s13046-021-02128-w.
   PubMed Web of Science ®Google Scholar
• Engels EA, Frisch M, Goedert JJ, et al. Merkel cell carcinoma and HIV infection. Lancet. 2002;359(9305):497–498. doi: 10.1016/S0140-6736(02)07668-7.
   PubMed Web of Science ®Google Scholar
• Mao X, Xu J, Wang W, et al. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer. 2021;20(1):131. doi: 10.1186/s12943-021-01428-1.
   PubMed Web of Science ®Google Scholar
• Xiang X, et al. Targeting tumor-associated macrophages to synergize tumor immunotherapy. Signal Transduct Target Ther. 2021;6(1):75.
   PubMed Web of Science ®Google Scholar
• Chen D, Zhang X, Li Z, et al. Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages. Theranostics. 2021;11(3):1016–1030. doi: 10.7150/thno.51777.
   PubMed Web of Science ®Google Scholar
• Biffi G, Tuveson DA. Diversity and biology of cancer-associated fibroblasts. Physiol Rev. 2021;101(1):147–176. doi: 10.1152/physrev.00048.2019.
   PubMed Web of Science ®Google Scholar